Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 287257011000036118 | bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 287258011000036117 | bupivacaine hydrochloride monohydrate 50 mg / 20 mL + epinephrine 50 microgram / 20 mL injection, 20 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | Is a | bupivacaine + adrenaline (epinephrine) | true | Inferred relationship | Some | ||
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | has intended active ingredient | adrenaline (epinephrine) | true | Inferred relationship | Some | 1511246376 | |
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | has Australian BoSS | adrenaline (epinephrine) | true | Inferred relationship | Some | 1511246376 | |
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | has intended active ingredient | bupivacaine | true | Inferred relationship | Some | 274129599 | |
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | has Australian BoSS | bupivacaine hydrochloride monohydrate | true | Inferred relationship | Some | 274129599 | |
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1511246377 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bupivacaine 0.25% with Adrenaline 1 in 400 000 (Pfizer) injection, 20 mL vial | Is a | True | bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | Inferred relationship | Some | |
| Bupivadren 0.25% with Adrenaline 1 in 400 000 injection, 20 mL vial | Is a | True | bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | Inferred relationship | Some | |
| Marcain 0.25% with Adrenaline 1 in 400 000 injection, 20 mL vial | Is a | True | bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | Inferred relationship | Some | |
| bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, 5 x 20 mL vials | has MPUU | True | bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR